Waters Stock Based Compensation Over Time
| WAT Stock | USD 368.63 4.67 1.25% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Waters Performance and Waters Correlation. Waters |
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Waters. If investors know Waters will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Waters listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.064 | Earnings Share 10.71 | Revenue Per Share | Quarterly Revenue Growth 0.065 | Return On Assets |
The market value of Waters is measured differently than its book value, which is the value of Waters that is recorded on the company's balance sheet. Investors also form their own opinion of Waters' value that differs from its market value or its book value, called intrinsic value, which is Waters' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Waters' market value can be influenced by many factors that don't directly affect Waters' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Waters' value and its price as these two are different measures arrived at by different means. Investors typically determine if Waters is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Waters' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Stock Based Compensation Analysis
Compare Waters and related stocks such as IDEXX Laboratories, IQVIA Holdings, and Charles River Labora Stock Based Compensation Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IDXX | 138 K | 15.5 M | 16 M | 16.5 M | 18.1 M | 19.9 M | 19.9 M | 23.5 M | 25.2 M | 39.3 M | 31 M | 37.8 M | 49.8 M | 59.7 M | 60.3 M | 63.3 M |
| IQV | 17.3 M | 14.1 M | 25.9 M | 22.8 M | 30 M | 37.8 M | 80 M | 106 M | 113 M | 146 M | 95 M | 170 M | 194 M | 217 M | 206 M | 108.2 M |
| CRL | 8.2 M | 21.7 M | 21.9 M | 24.5 M | 31 M | 40.1 M | 43.6 M | 44 M | 47.3 M | 57.3 M | 56.3 M | 71.5 M | 73.6 M | 72 M | 69.9 M | 37.8 M |
| RVTY | 19.3 M | 15.5 M | 20.6 M | 14.1 M | 14.1 M | 17.3 M | 17.2 M | 25.4 M | 28.8 M | 31.5 M | 29.1 M | 32.8 M | 51.5 M | 41.4 M | 37.8 M | 27.4 M |
| MTD | 8 M | 12.3 M | 13.2 M | 12.6 M | 13.6 M | 14.2 M | 15.3 M | 16.6 M | 17.6 M | 18.3 M | 18.7 M | 19.6 M | 19.7 M | 17.9 M | 20 M | 13.3 M |
| DHR | 86 M | 95.6 M | 109.9 M | 117.7 M | 121.1 M | 139 M | 129.8 M | 139.4 M | 151.4 M | 158.8 M | 187 M | 218 M | 336 M | 306 M | 288 M | 178.5 M |
| TMO | (10.6 M) | 80.2 M | 78.2 M | 90.9 M | 117.1 M | 125 M | 133.5 M | 159 M | 181 M | 181 M | 196 M | 230 M | 307 M | 278 M | 301 M | 316.1 M |
| TWST | 857 K | 857 K | 857 K | 857 K | 857 K | 857 K | 1.9 M | 3 M | 11.2 M | 17.1 M | 37 M | 79.7 M | 30.3 M | 50.9 M | 58.6 M | 61.5 M |
| ICLR | 414 K | 9.4 M | 10.2 M | 14.2 M | 22.7 M | 33.3 M | 40.3 M | 21.6 M | 28.1 M | 26.8 M | 26.3 M | 133.8 M | 70.5 M | 55.7 M | 45.9 M | 32.5 M |
| ILMN | 5.8 M | 92.1 M | 94.3 M | 105.8 M | 152.6 M | 132.6 M | 129.1 M | 164 M | 193 M | 194 M | 194 M | 754 M | 366 M | 380 M | 370 M | 388.5 M |
| SHC | 6.9 M | 6.9 M | 6.9 M | 6.9 M | 6.9 M | 6.9 M | 6.9 M | 6.9 M | 6.9 M | 6.9 M | 11 M | 13.9 M | 21.2 M | 32.2 M | 36.8 M | 20.3 M |
Waters and related stocks such as IDEXX Laboratories, IQVIA Holdings, and Charles River Labora Stock Based Compensation description
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.My Equities
My Current Equities and Potential Positions
| Waters | WAT |
| Classification | Healthcare |
| Location | Massachusetts; U.S.A |
| Exchange | New York Stock Exchange |
USD 368.63
Additional Tools for Waters Stock Analysis
When running Waters' price analysis, check to measure Waters' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Waters is operating at the current time. Most of Waters' value examination focuses on studying past and present price action to predict the probability of Waters' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Waters' price. Additionally, you may evaluate how the addition of Waters to your portfolios can decrease your overall portfolio volatility.